/PRNewswire/ Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, will host a key opinion leader.
SAN DIEGO, March 18, 2022 /PRNewswire/ Viracta Therapeutics, Inc. , a precision oncology company targeting virus-associated malignancies, today announced that the Compensation Committee of. | March 18, 2022
/PRNewswire/ Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that the.
/PRNewswire/ Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that the.
Viracta Therapeutics Announces the Appointment of Ayman El-Guindy, Ph D , as Chief Scientific Officer and Key Additions to Management Team apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.